Synopsys (SNPS), a company that provides software for designing computer chips, is planning to sell around $10 billion worth of bonds as early ...
Despite a dip in overall revenue, Synopsys Inc (SNPS) sees growth in Design Automation and advances in AI-driven solutions.
The veteran politician, a former minister in previous SNP governments, said it has been an ‘honour’ to represent Cowdenbeath.
2d
Hosted on MSNSNPS Plunges 21% in a Year: Should You Hold or Fold the Stock?Synopsys SNPS shares plunged 20.8% over the past year, underperforming the Zacks Computer - Software industry, Zacks Computer ...
Synopsys (NASDAQ:SNPS – Free Report) had its price target decreased by Piper Sandler from $655.00 to $653.00 in a report released on Thursday,Benzinga reports. Piper Sandler currently has an ...
In a report released yesterday, Clarke Jeffries from Piper Sandler maintained a Buy rating on Synopsys (SNPS – Research Report), with a price ...
Q1 2025 Earnings Conference Call February 26, 2025 5:00 PM ETCompany ParticipantsTrey Campbell - SVP, IRSassine Ghazi - ...
Rosenblatt Securities restated their buy rating on shares of Synopsys (NASDAQ:SNPS – Free Report) in a research report sent ...
Synopsys (SNPS) came out with quarterly earnings of $3.03 per share, beating the Zacks Consensus Estimate of $2.81 per share. This compares to earnings of $3.56 per share a year ago. These figures ...
Synopsys (SNPS) shares were active in extended-trading on Wednesday after the electronic design automation company posted ...
News Medical on MSN4d
Exploring the role of SNPs in early diagnosis of coronary microvascular dysfunctionA new review highlights the potential role of single nucleotide polymorphisms (SNPs) in improving the early diagnosis and targeted intervention of coronary microvascular dysfunction (CMD)—a condition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results